Comparison of the effects of guided walking in a suggested environment and free walking for people with Chronic Obstructive Pulmonary Disease

Not Applicable

• Conditions: Pulmonary Disease, Chronic Obstructive; J44

• Registration Number: RBR-4tfwdhp
• Lead Sponsor: niversidade Federal de Juiz de Fora

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-08-21
• Last Update Posted: 18 September 2023
• Study Completion: 2026-12-10

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Individuals with a confirmed diagnosis of Chronic Obstructive Pulmonary Disease (COPD) will be studied based on the criteria of the Global Initiative for Chronic Obstructive Lung Disease (GOLD); of both sexes; with the post-bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio being <70% and FEV1 <80% of the predicted value 29; aged over 18 years; clinically stable; without unstable cardiovascular diseases; neurological; musculoskeletal disorders and in conditions to carry out the proposed evaluations and intervention;

Exclusion Criteria

Participants unable to perform or understand the study assessments due to physical or psychological impairment will be excluded from the study; primary diagnosis of a respiratory disease other than Chronic Obstructive Pulmonary Disease (COPD); in support of oxygen therapy; with orthopedic and/or neurological limitations that prevent the performance of the tests; recent hospitalization (last 3 months); cognitive impairment identified by a score of 4 or less on the Six Item Screener; or who expressed their desire to withdraw from the study;

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected to find an improvement in the level of physical activity of 30 minutes/day compared to the control group. Physical activity will be assessed using the Actigraph GT3X accelerometer (Actigraph LLC, USA), a validated and reliable physical activity monitor for use in individuals with chronic obstructive pulmonary disease (COPD). Data collected one week before and one week after the intervention.